These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26839719)

  • 21. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice.
    Zarrindast MR; Dorrani M; Lachinani R; Rezayof A
    Neurosci Res; 2010 May; 67(1):25-32. PubMed ID: 20144666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
    Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
    Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
    Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
    Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
    Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
    Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review.
    Kruk-Slomka M; Dzik A; Budzynska B; Biala G
    Mol Neurobiol; 2017 Dec; 54(10):8332-8347. PubMed ID: 27924524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Influence of CB2-Receptor Ligands on the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in the Passive Avoidance Test.
    Kruk-Slomka M; Dzik A; Biala G
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807499
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
    Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
    Cagni P; Barros M
    Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
    Coruzzi G; Adami M; Coppelli G; Frati P; Soldani G
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):715-8. PubMed ID: 10619190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of intracerebroventricular administration of cannabinergic drugs on morphine state-dependent memory in the step-down passive avoidance test.
    Zarrindast MR; Kangarlu-Haghighi K; Khalilzadeh A; Fazli-Tabaei S
    Behav Pharmacol; 2006 May; 17(3):231-7. PubMed ID: 16572001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
    Haller J; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.
    Ding Z; Cowan A; Rawls SM
    Brain Res; 2005 Dec; 1065(1-2):147-51. PubMed ID: 16309633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A.
    Pozzi O; Misiano P; Clark GD; Visentin L
    Pharmacology; 2003 Nov; 69(3):158-63. PubMed ID: 14512703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
    Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
    Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory.
    Clarke JR; Rossato JI; Monteiro S; Bevilaqua LR; Izquierdo I; Cammarota M
    Neurobiol Learn Mem; 2008 Sep; 90(2):374-81. PubMed ID: 18524639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.
    Cluny NL; Vemuri VK; Chambers AP; Limebeer CL; Bedard H; Wood JT; Lutz B; Zimmer A; Parker LA; Makriyannis A; Sharkey KA
    Br J Pharmacol; 2010 Oct; 161(3):629-42. PubMed ID: 20880401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
    Klegeris A; Bissonnette CJ; McGeer PL
    Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.